U.S., Feb. 14 -- ClinicalTrials.gov registry received information related to the study (NCT06824818) titled 'Study to Assess the Feasibility of Stopping Prostate Cancer Treatment Early in Elderly Patients' on Jan. 31.
Brief Summary: This study seeks to identify if it is feasible to stop Luteinizing Hormone-Releasing Hormone (LHRH) Agonist Therapy in elderly men with prostate cancer. We hypothesize that elderly prostate cancer patients on long term androgen ablation with LHRH agonists will be permanently castrated and do not require ongoing LHRH agonist therapy. Participants will be monitored by testosterone testing throughout study.
Study Start Date: June, 2025
Study Type: INTERVENTIONAL
Condition:
Elderly
Prostate Cancer
Intervention...